Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques.
about
Choice and Design of Adjuvants for Parenteral and Mucosal VaccinesSynthetic DNA vaccine strategies against persistent viral infectionsImmune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challengeAn Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.Interferon induction and function at the mucosal surface.IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection.Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector.HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesClinical applications of DNA vaccines: current progress.Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challengeIL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaquesNon-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses.IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunizationPreclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.Host genetics in immune-mediated hepatitis C virus clearance.Electroporation delivery of DNA vaccines: prospects for successVibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection.Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.Current challenges for cancer vaccine adjuvant development.
P2860
Q26783488-7A582017-DBA9-4B6C-9C18-9942B720D011Q27016078-D2DDB085-7AA2-4E5A-AF18-82D97752F7A4Q28740359-A058753A-7DAD-4FF8-A626-36BDB48412F1Q30375785-F2250385-2DD9-44CE-A179-5748023F6B3FQ30661545-CE08F6E6-484D-4584-BB30-754DE083015FQ34147632-B38E6B37-7D9A-44E5-91DA-999D27AC20ABQ34262131-FA00FF04-C70A-4BBB-B62C-2AD834689EBAQ35032794-DA918439-1DA3-46CB-8C74-1C08AA5A56E4Q35452312-5C7CB4D4-D557-4A23-8742-3B029E026097Q36258203-28DB9782-08CA-4E27-B3C6-B751204A663AQ36694836-1C505728-FE9D-47A9-8EF4-EAABDC91A26FQ36694887-5F3AF77E-C233-4450-B552-7A4D351A7709Q36947326-7A250C66-E316-4F05-A855-66C3254A683FQ37684017-D31C54ED-B296-44A0-9D58-C46F059EF42BQ37862746-FEA87119-0383-4751-AD43-7CFF3355825DQ37870313-F0392B5A-2F1E-446D-9E8D-03F25D4E4BB8Q38641127-BEE0EB81-9D0D-455E-BD0F-9F179401D2D6Q38668279-CDF56AE8-E4BB-47DE-8EFB-4D0703AD44A7Q38730774-7D2CFE81-F42C-4059-B8F5-43713F2B2B43Q41435861-6F9CAE86-ED31-4EE7-A193-DE1667E30BEAQ48160317-7B49DF0C-379E-4BC0-AA0B-156FA70E6FE2
P2860
Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Unique Th1/Th2 phenotypes indu ...... adjuvants in rhesus macaques.
@en
Unique Th1/Th2 phenotypes indu ...... hases by use of interleukin-12
@nl
type
label
Unique Th1/Th2 phenotypes indu ...... adjuvants in rhesus macaques.
@en
Unique Th1/Th2 phenotypes indu ...... hases by use of interleukin-12
@nl
prefLabel
Unique Th1/Th2 phenotypes indu ...... adjuvants in rhesus macaques.
@en
Unique Th1/Th2 phenotypes indu ...... hases by use of interleukin-12
@nl
P2093
P2860
P356
P1476
Unique Th1/Th2 phenotypes indu ...... adjuvants in rhesus macaques.
@en
P2093
Amir S Khan
Bernadette Ferraro
David B Weiner
Matthew P Morrow
Niranjan Y Sardesai
Panyupa Pankhong
P2860
P304
P356
10.1128/CVI.00181-10
P50
P577
2010-08-04T00:00:00Z